U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Medication delivery system phase one

Patent 4926852 Issued on May 22, 1990. Estimated Expiration Date: Icon_subject September 30, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

2788784

2944546

Drug delivery method and inhalation device therefor
Patent #: 4484577
Issued on: 11/27/1984
Inventor: Sackner ,   et al.

Metered dose inhaler
Patent #: 4534343
Issued on: 08/13/1985
Inventor: Nowacki ,   et al.

Dual-range aspirator device
Patent #: 4612926
Issued on: 09/23/1986
Inventor: Boiarski ,   et al.

Collapsible inhalation valve
Patent #: 4796614
Issued on: 01/10/1989
Inventor: Nowacki ,   et al.

Engine output control system Patent #: 4919097
Issued on: 04/24/1990
Inventor: Mitui, et al.

Inventors

Assignee

Application

No. 251454 filed on 09/30/1988

US Classes:

128/200.23, Pre-pressurized container holding medicament128/203.24With gas flow control means other than pivotal or removable closure

Examiners

Primary: Hindenburg, Max
Assistant: Reichle, K. M.

Attorney, Agent or Firm

Foreign Patent References

  • 933216 FR 04/13/2012
  • 2110543 GB 06/13/1983

International Classes

A61M 011/00
205.25

Abstract

An apparatus for use in inhaling pharmaceutical aerosols. The apparatus includes a mouthpiece and a rigid housing for receiving an aerosolized medicine. The rigid housing has one or more orifices which are spaced from the mouth piece so that flow through the housing is possible but is limited by the orifice(s) to a desired volumetric flow rate. The patient is aided by having the initial velocity of the aerosolized medicine reduced to zero by virtue of the initial delivery of the same to the housing interior, and by having the volumetric flow rate of the inhaled medication maintained below required limits thereby providing the conditions for optimal dosing. Further, the ability of the patient to inhale to total lung capacity with the flow through chamber enhances penetration of aerosolized drug to the lung periphery, and improves the ease of use for the patient.

PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?